Navigation Links
Haagen-Dazs gift to support Penn State honeybee research
Date:2/20/2008

As the pollination season approaches in Pennsylvania and the Northeast, scientists at Penn State and elsewhere continue to seek answers to the decline of the nation's honeybees and other pollinators, which are critical to the production of $15 billion worth of crops in the United States. To assist in this effort, a major ice cream brand has stepped up to support honeybee research and education.

Haagen-Dazs has announced a gift of $150,000 toward honeybee-related programs in Penn State's College of Agricultural Sciences. The college has taken a lead role in investigating the cause or causes of Colony Collapse Disorder (CCD), a mysterious ailment that has decimated honeybee colonies across the country over the last 18 months.

Haagen-Dazs also will contribute $100,000 to the Harry H. Laidlaw Jr. Honey Bee Research Facility at the University of California, Davis.

The donations are part of the company's "Haagen-Dazs Loves Honey Bees" consumer education campaign aimed at generating awareness among ice cream lovers about the dire situation facing managed and wild pollinators and what can be done to help.

"Haagen-Dazs ice cream is made from the finest all-natural ingredients, and the plight of the honeybee could mean many of the ingredients used in our top flavors, like Vanilla Swiss Almond and Strawberry, would be difficult to source," said Haagen-Dazs brand manager Josh Gellert.

Diana Cox-Foster, Penn State professor of entomology and co-chair of a national working group of CCD researchers, said Haagen-Dazs' contribution will allow Penn State to purchase two expensive pieces of equipment that will enable faster processing of samples and aid in the molecular detection and identification of viruses, pesticides and other substances potentially harmful to honeybees and other pollinators.

The gift also will support training of graduate and undergraduate students by providing small grants for student research on bee-re
'/>"/>

Contact: Chuck Gill
cdg5@psu.edu
814-863-2713
Penn State
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. M2SYS Partners with SecuGen Corporation to Support Market Leading Hamster Plus Fingerprint Reader with Auto-On Technology
2. Diet support helps chronic kidney patients
3. Entrust Continues Leadership by Adding Support for Next-generation E-Passports
4. $10 million gift to support cutting-edge epigenome center at USC
5. Grant supports study of abnormal ring-shaped chromosomes
6. Fossil record supports evidence of impending mass extinction
7. An intelligent new way to support the teaching of evolution
8. Gene study supports single main migration across Bering Strait
9. IdentiPHI Opens Paris Office to Boost European Sales and Support
10. Breakthrough technology observes synapse in real time, supporting theory of vesicular recycling
11. Widespread support for nonembryonic stem cell research, VCU Life Sciences Survey shows
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... --  LaunchKey , the first decentralized mobile authentication and ... Things era, today announced the close of $3 million ... by Metamorphic Ventures with participation from ENIAC Ventures, Crosslink ... LaunchKey has raised $4 million to date, and will ... bring LaunchKey to market in 2015. LaunchKey ...
(Date:12/17/2014)... N.C. , Dec. 16, 2014 Valencell, ... licensed its PerformTek biometric technology to industry leaders such ... highly accurate, clinically validated, biometric wearable products. These products ... 6-9 in Las Vegas . ... technology is accurate, flexible and robust – with the ...
(Date:12/11/2014)... Research and Markets , ... http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced the addition of the ...  report to their offering. One ... in technology. With continuous advances in technology, it ... latest standard that meets the needs and expectations ...
Breaking Biology News(10 mins):LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... new studies shed light on the complex defense mechanisms ... of which could lead to new, more effective antibiotics ... of antibiotic resistance. The studies, both of which target ... will appear in the February 17 inaugural print issue ...
... San Francisco, is just one of the many American ... trial in India. , The trial is studying ... Under Guidance): a reversible, nonhormonal contraceptive that provides 10 ... procedure. Researchers received approval this week to begin enrolling ...
... at just four months old, babies are able to ... according to brightness, shape, and how close the visual ... very young infants are much more capable of organising ... The study also has implications for understanding certain developmental ...
Cached Biology News:Pair of studies offer new clues to combat antibiotic resistance 2New male contraceptive clears hurdle 2New male contraceptive clears hurdle 3Infants can organise visual information at just four months 2Infants can organise visual information at just four months 3
(Date:12/19/2014)... In contrast to traditional LED lights where the spectrum ... proprietary LED technology to incorporate their spectra in a ... critical in low proximity installations. The Valoya L-series offers ... which is up to four times longer than commonly ... was clearly higher when compared to traditional fluorescent or ...
(Date:12/19/2014)... San Diego, CA (PRWEB) December 18, 2014 ... announces a limited time special on Sartorius Biohit ... 1 Free on mLINE pipettes, Picus Electronic Pipette Trade-in ... recommended by Health and Safety officers around the world. ... repetitive manual pipetting. Other features include:, , ...
(Date:12/19/2014)... 18, 2014 Egenix, Inc. is pleased to announce ... of the Board, to succeed Donald Fresne ; Mr. ... continue as a member of the Board.  In recognition of ... the company over almost twenty years, the Board designated Mr. ... Directors has established a Search Committee to find a suitable ...
(Date:12/19/2014)... -- Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company ... announced the results of its annual general meeting of ... year in Relmada,s history and it set the stage ... Sergio Traversa , chief executive officer of Relmada. "Over ... human resource and clinical development objectives that position Relmada ...
Breaking Biology Technology:Major Pipette Distributor Pipette.com Announces Sartorius Year End Specials 2Relmada Therapeutics Announces Results of Annual Shareholders Meeting 2
... 16 CEL-SCI Corporation (NYSE Amex: ... prevention and treatment of infectious diseases and a late-stage oncology ... (FDA) has indicated that the Company can proceed with its ... LEAPS-H1N1 treatment on the white blood cells of hospitalized H1N1 ...
... , , EAST BRUNSWICK, N.J. Sept. 16 ... on September 14, 2009, the Company completed a Type A meeting with ... Letter (CRL) received by Savient on July 31, 2009 regarding the Company,s ... gout in patients refractory to conventional therapy. , ...
... ... FDA, including increased scrutiny of complex medical devices, automating your QA process is more ... one of the leading medical device software engineering and QA consulting firms in the ... , ...
Cached Biology Technology:CEL-SCI to Commence First Clinical Study with Hospitalized H1N1 Infected Patients 2CEL-SCI to Commence First Clinical Study with Hospitalized H1N1 Infected Patients 3CEL-SCI to Commence First Clinical Study with Hospitalized H1N1 Infected Patients 4Savient Provides Update on Meeting with U.S. Food and Drug Administration for KRYSTEXXA(TM) 2Savient Provides Update on Meeting with U.S. Food and Drug Administration for KRYSTEXXA(TM) 3Savient Provides Update on Meeting with U.S. Food and Drug Administration for KRYSTEXXA(TM) 4Savient Provides Update on Meeting with U.S. Food and Drug Administration for KRYSTEXXA(TM) 5Savient Provides Update on Meeting with U.S. Food and Drug Administration for KRYSTEXXA(TM) 6Implementing QA Automation Tools in an FDA Controlled Software Environment, a Free Webinar 2
Allophycocyanin (APC) anti-human CD193 (CCR3, CKR3) 25 tests...
CCNI Antibody...
Rabbit polyclonal to IL23 P19 ( Abpromise for all tested applications). Antigen: Synthetic 16 amino acid peptide from near the amino terminus of human IL23 P19 Entrez Gene ID: 51561 Swiss...
3M Imidazole Solution 125 ml...
Biology Products: